Year-over-year net earnings per share growth for the last 12 months: Avid Bioservices Inc. (CDMO)

Avid Bioservices Inc (CDMO) - corporate logo

Avid Bioservices, Inc. (CDMO) serves as a technological hub, providing the engineering foundation for the synthesis of complex proteins and antibodies. Quarterly growth in earnings per share demonstrates a turning point driven by flawless plant compliance and the trust of industry behemoths. Stability is ensured by the high switching costs for clients moving between facilities. The current level of -80.40 reflects the real-time value of this financial metric.

avidbio.com (CDMO) Year-over-year net earnings per share change for the last twelve months: for the period 07/04/2022 - 02/16/2025

Financial and market metric breakdowns for Avid Bioservices, Inc. (CDMO)

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Analysis of all company metrics:Avid Bioservices, Inc. - CDMO
Finished products of Avid Bioservices Inc

The efficiency of Avid Bioservices, Inc. (CDMO) in the contract biologics manufacturing segment depends directly on the scaling of orders from biotech startups. The quarterly earnings per share dynamics aggregate net income growth rates, converting quarterly data into a daily trend to assess the business's real yield. This metric allows investors to filter out market noise and objectively measure the company's fundamental progress.